Genelux Corp. (GNLX)
2.52
-0.02
(-0.79%)
USD |
NASDAQ |
Sep 09, 10:55
Genelux Total Assets (Quarterly) : 26.20M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.20M |
| March 31, 2026 | 32.37M |
| December 31, 2025 | 19.03M |
| September 30, 2025 | 24.99M |
| June 30, 2025 | 32.25M |
| March 31, 2025 | 38.98M |
| December 31, 2024 | 34.72M |
| September 30, 2024 | 40.27M |
| June 30, 2024 | 45.18M |
| March 31, 2024 | 24.68M |
| December 31, 2023 | 27.89M |
| Date | Value |
|---|---|
| September 30, 2023 | 34.07M |
| June 30, 2023 | 31.36M |
| March 31, 2023 | 14.62M |
| December 31, 2022 | 5.531M |
| September 30, 2022 | 6.189M |
| June 30, 2022 | 9.131M |
| March 31, 2022 | 10.20M |
| December 31, 2021 | 8.126M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 10.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 488.54M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.09M |
| Shareholders Equity (Quarterly) | 16.11M |
| Debt to Equity Ratio | 0.1502 |
| Current Ratio | 2.394 |
| Net Debt Paydown Yield | -0.09% |